Assessing the effect of HIV vaccination on infectiousness

Statistics in Medicine

Volumn 15, Issue 21-22, 1996, Pages 2393-2404

  Rida, Wasima N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ACTIVITY; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL;

EID: 0029857006     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0258(19961130)15:22<2393::aid-sim458>3.0.co;2-w     Document Type: Conference Paper

References (19)

1. Weiser, B., Nachman, S., Tropper, P., Viscosi, K. H., Grimson, R., Baxter, G., Fang, G., Reyelt, C., Hutcheon, N. and Burger, H. 'Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load', Proceedings of the National Academy of Science, U.S.A., 91, 8037-8041 (1994).
2. Jacquez, J. A., Koopman, J. S., Simon, C. P. and Longini, Jr., I. M. 'Role of the primary infection in epidemics of HIV infection in gay cohorts', Journal of Acquired Immune Deficiency Syndromes, 7, 1169-1184 (1994).
3. Mellors, J. W., Kingsley, L. A., Rinaldo, Jr., C. R., Todd, J. A., Hoo, B. S., Kokka, R. P. and Gupta P. 'Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion', Annals of Internal Medicine, 122, 573-579 (1995).
4. Putkonen, P., Thorstensson, R., Albert, J., Hild, K., Norsby, E., Biberfeld, P. and Biberfeld, G. 'Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection', AIDS, 4, 783-789 (1990).
5. Putkonen, P., Walther, L., Zhang, Y-J., Li, S-L., Nilsson, C., Albert, J., Biberfeld, P., Thorstensson, R. and Biberfeld, G. 'Long-term protection against SIV-induced disease in macaques vaccinated with live attenuated HIV-2 vaccine', Nature Medicine, 1, 914-918 (1995).
6. Hoff, R. and Barker, L. 'Trial objectives and end points for measuring the efficacy of HIV vaccines', Infectious Agents and Disease, 4, 95-101 (1995).
7. Koopman, J. S. and Little, R. J. 'Assessing HIV vaccine effects', American Journal of Epidemiology, 142, 1113-1120 (1995).
8. Clark, S. J., Saag, M. S., Decker, W. D., Campbell-Hill, S., Roberson, J. L., Veldkamp, P. J., Kappes, J. C., Hahn, B. H. and Shaw, G. M. 'High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection', New England Journal of Medicine, 324, 954-960 (1991).
9. Smith, P. G., Rodrigues, L. C. and Fine, P. E. M. 'Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies', International Journal of Epidemiology, 13, 87-93 (1984).
10. Halloran, M. E., Longini, Jr., I. M., Haber, M. J., Struchiner, C. J. and Brunet, R. C. 'Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field', Statistics in Medicine, 13, 357-377 (1994).
11. Bremaud, P. Point Processes and Queues, Martingale Dynamics, Springer, New York, 1981.
12. Kunita, H. and Watanabe, S. 'On square integrable martingales', Nagoya Mathematical Journal, 30, 209-245 (1967).
13. Haber, M., Longini, Jr., I. M. and Halloran, M. E. 'Estimation of vaccine efficacy in outbreaks of acute infectious diseases', Statistics in Medicine, 10, 1573-1584 (1991).
14. O'Neill, R. T. 'On sample sizes to estimate the protective efficacy of a vaccine', Statistics in Medicine, 7, 1279-1288 (1988).
15. Breslow, N. E. and Day, N. E. Statistical Methods in Cancer Research, Volume 1 - the analysis of case-control studies, International Agency for Research on Cancer, Lyon, 1980, p. 134.
16. Rida, W. N., Fast, P. E., Hoff, R. and Fleming, T. R. 'Intermediate sized trials for the evaluation of HIV vaccine candidates: a workshop summary', (in preparation).
17. Rida, W. N. and Lawrence, D. N. 'Some statistical issues in HIV vaccine trials', Statistics in Medicine, 13, 2155-2177 (1994).
18. Halloran, M. E., Longini, Jr., I. M. and Struchiner, C. J. 'Estimability and interpretation of vaccine efficacy using frailty mixing models', American Journal of Epidemiology 144, 83-97 (1996).
19. Becker, N. and Hopper, J. L. 'The infectiousness of a disease in a community of households', Biometrika, 70, 29-39 (1983).